Because the absolute bioavailability of fexofenadine hydrochloride has not been established, it is unknown if the fecal component represents primarily unabsorbed drug or the result of biliary excretion. Each tablet contains 30,
Allegra Without Prescription or 180 mg fexofenadine hydrochloride (depending on the dosage strength) and the following excipients: croscarmellose sodium, magnesium stearate, microcrystalline cellulose, and pregelatinized starch.
Onset of action for reduction in total symptom scores, excluding nasal congestion, was observed at 60 minutes compared to placebo following a single 60 mg fexofenadine hydrochloride dose administered to subjects with seasonal allergic rhinitis who were exposed to ragweed pollen in an environmental exposure unit. Moreover, no sedative or other central nervous system effects were observed. The aqueous tablet film coating is made from hypromellose, iron oxide blends, polyethylene glycol, povidone, silicone dioxide, and titanium dioxide. However, no additional benefit of the 120 or 240 mg fexofenadine hydrochloride twice daily dose was seen over the 60 mg twice Drug Allegra dose Drug Allegra reducing symptom scores. Fexofenadine hydrochloride pharmacokinetics are linear for oral doses up to a total daily dose of 240 mg (120 mg twice daily).
The tablet formulations are bioequivalent to the capsule when administered at equal doses.
In vivo animal studies also suggest that in addition to enhancing absorption, ketoconazole decreases fexofenadine gastrointestinal secretion, while erythromycin may also decrease biliary excretion. There were no significant differences in the effect of fexofenadine hydrochloride across subgroups of subjects defined by gender, age, weight, and race.
A dose of 5 mL of ALLEGRA Oral Suspension containing 30 mg of fexofenadine hydrochloride is bioequivalent to a 30 mg dose of ALLEGRA tablets. It is freely soluble in methanol and ethanol, slightly soluble in chloroform and water, and insoluble in hexane. Fruit juices such as grapefruit, orange and apple may reduce the bioavailability and exposure of fexofenadine Drug Allegra .
In 1 clinical trial conducted with ALLEGRA 60 mg capsules, and in 1 clinical
Allegra Network conducted with ALLEGRA-D 12 Hour extended release tablets, onset of action was seen within 1 to 3 hours. Radiolabeled tissue distribution studies in rats indicated that fexofenadine does not cross the blood-brain barrier. The pharmacokinetics of fexofenadine hydrochloride in subjects with seasonal allergic rhinitis and subjects with chronic urticaria were similar to those in
Allegra Prices subjects.